Charles G. Phillips III, Director at NovoCure Ltd (NVCR), sold 95,100 shares at $52.09 ($5.0M) on 2019-05-29, disclosed to the SEC on 2019-05-31.
Open-market sale of $5.0M NVCR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $52.08 | 22,200 | $1.2M | 23.3% |
| 2 | $52.09 | 16,326 | $850K | 17.1% |
| 3 | $52.09 | 47,080 | $2.5M | 49.4% |
| 4 | $52.82 | 1,400 | $74K | 1.5% |
| 5 | $52.84 | 2,920 | $154K | 3.1% |
| 6 | $52.96 | 5,174 |
| $274K |
| 5.5% |
| Total | $52.17 avg | 95,100 | $5.0M | 100% |
| Filing → |
| NVCR | SELL | 2019-05-31 | $8.7M | — | Filing → |
| NVCR | SELL | 2019-05-31 | $2.5M | — | Filing → |
| NVCR | SELL | 2018-05-30 | $1.5M | — | Filing → |